Susanne Lütje studied Medical Biology and Medicine (MD) at the Radboud University Nijmegen. For her graduation thesis, she worked on natural killer cell-based immunotherapy against cancer at the Center for Infectious Medicine at the Karolinska Institute in Stockholm, Sweden. In 2014, she finished her PhD thesis entitled ‘Antibody-based imaging of prostate cancer’ at the department of Radiology and Nuclear Medicine at the Radboud University Medical Center Nijmegen. During her PhD project, she was visiting researcher at the Department of Radiology and Radiological Sciences at Johns Hopkins University in Baltimore, US, where she worked on intravital-fluorescence microscopy. After obtaining her PhD, she did clinical residencies in Oncology at the West German Cancer Center and in Nuclear Medicine at the Clinic for Nuclear Medicine at University Hospital Essen, Germany, where she finished her second doctoral degree focusing on PSMA-targeted photodynamic therapy of prostate cancer. At present, she works as a postdoc in the NucMed group, where she is starting her own research group with a focus on improving diagnosis and therapy of prostate cancer with radionuclide and fluorescence based approaches using multi-modal PSMA targeting molecules. In addition, she works on intra-operative imaging and image-guided surgery of urological cancers and develops strategies to potentiate anti-cancer immune responses using immune checkpoint inhibitors such as PD-1 and PD-L1.